共 50 条
Enhanced recovery after surgery (ERAS) protocol improves patient outcomes in free flap surgery for head and neck cancer
被引:6
作者:
Nieminen, Teija
[1
,2
,4
,7
]
Tapiovaara, Laura
[3
]
Back, Leif
[3
,4
]
Lindford, Andrew
[4
,5
]
Lassus, Patrik
[4
,5
]
Lehtonen, Lasse
[4
,6
]
Makitie, Antti
[3
,4
,7
]
Keski-Santti, Harri
[3
,4
]
机构:
[1] Univ Helsinki, HUS, Dept Perioperat & Intens Care Med, POB 340,Haartmaninkatu 4, Helsinki 00029, Finland
[2] Helsinki Univ Hosp, HUS, POB 340,Haartmaninkatu 4, Helsinki 00029, Finland
[3] Univ Helsinki, Dept Otorhinolaryngol Head & Neck Surg, Helsinki, Finland
[4] Helsinki Univ Hosp, Helsinki, Finland
[5] Univ Helsinki, Dept Plast Surg, Helsinki, Finland
[6] Univ Helsinki, HUS Diagnost Ctr, Helsinki, Finland
[7] Univ Helsinki, Fac Med, Res Program Syst Oncol, Helsinki, Finland
关键词:
ERAS;
Enhanced recovery after surgery;
Head and neck cancer;
Free flap surgery;
Microvascular reconstruction;
FREE TISSUE TRANSFER;
POSTOPERATIVE COMPLICATIONS;
MAJOR HEAD;
PERIOPERATIVE CARE;
RECONSTRUCTION;
PROPHYLAXIS;
OPERATIONS;
COHORT;
D O I:
10.1007/s00405-023-08292-3
中图分类号:
R76 [耳鼻咽喉科学];
学科分类号:
100213 ;
摘要:
Background In recent years, enhanced recovery after surgery (ERAS) guidelines have been developed to optimize pre-, intra-, and postoperative care of surgical oncology patients. The aim of this study was to compare management outcome of patients undergoing head and neck cancer (HNC) surgery with free flap reconstruction at our institution before and after the implementation of the ERAS guidelines.Methods This retrospective study comprised 283 patients undergoing HNC surgery with free flap reconstruction between 2013 and 2020. Patients operated before and after the implementation of the ERAS protocol in October 2017 formed the pre-ERAS group (n = 169), and ERAS group (n = 114), respectively.Results In the pre-ERAS group the mean length of stay (LOS) and intensive care unit length of the stay (ICU-LOS) were 20 days (range 7-79) and 6 days (range 1-32), and in the ERAS group 13 days (range 3-70) and 5 days (range 1-24), respectively. Both LOS (p < 0.001) and ICU-LOS (p = 0.042) were significantly reduced in the ERAS group compared to the pre-ERAS group. There were significantly fewer medical complications in the ERAS group (p < 0.003). No difference was found between the study groups in the surgical complication rate or in the 30-day or 6-month mortality rate after surgery.Conclusions We found reduced LOS, ICU-LOS, and medical complication rate, but no effect on the surgical complication rate after implementation of the ERAS guidelines, which supports their use in major HNC surgery.
引用
收藏
页码:907 / 914
页数:8
相关论文